Buneeva O, Medvedev A
Int J Mol Sci. 2025; 26(3).
PMID: 39941014
PMC: 11818313.
DOI: 10.3390/ijms26031248.
Rahman M, Wang X, Islam M, Akash S, Supti F, Mitu M
Front Pharmacol. 2022; 13:976385.
PMID: 36299886
PMC: 9590378.
DOI: 10.3389/fphar.2022.976385.
El-Gamal M, Salama M, Collins-Praino L, Baetu I, Fathalla A, Soliman A
Neurotox Res. 2021; 39(3):897-923.
PMID: 33765237
DOI: 10.1007/s12640-021-00356-8.
Rajput C, Sarkar A, Sachan N, Rawat N, Singh M
Neurochem Res. 2021; 46(3):425-438.
PMID: 33400024
DOI: 10.1007/s11064-020-03187-9.
Tripathi M, Kartawy M, Amal H
Redox Biol. 2020; 34:101567.
PMID: 32464501
PMC: 7256645.
DOI: 10.1016/j.redox.2020.101567.
Silymarin Protects Against Impaired Autophagy Associated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinsonism.
Tripathi M, Rasheed M, Mishra A, Patel D, Singh M
J Mol Neurosci. 2019; 70(2):276-283.
PMID: 31732923
DOI: 10.1007/s12031-019-01431-8.
Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.
Dixit A, Mehta R, Singh A
Cell Mol Neurobiol. 2019; 39(7):901-915.
PMID: 31190159
PMC: 11457823.
DOI: 10.1007/s10571-019-00700-9.
Malfunctioning of Chaperone-Mediated Autophagy in Parkinson's Disease: Feats, Constraints, and Flaws of Modulators.
Tripathi M, Rajput C, Mishra S, Rasheed M, Singh M
Neurotox Res. 2018; 35(1):260-270.
PMID: 29949106
DOI: 10.1007/s12640-018-9917-z.
Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
Rasheed M, Mishra A, Singh M
Neurochem Res. 2017; 42(12):3353-3361.
PMID: 28871472
DOI: 10.1007/s11064-017-2384-8.
Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration.
Singh A, Tripathi P, Prakash O, Singh M
Mol Neurobiol. 2015; 53(10):6849-6858.
PMID: 26660326
DOI: 10.1007/s12035-015-9577-4.
Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.
Leao A, Sarmento-Silva A, Santos J, Ribeiro A, Silva R
Brain Pathol. 2015; 25(4):377-90.
PMID: 25726735
PMC: 8029054.
DOI: 10.1111/bpa.12253.
Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin.
Monti C, Bondi H, Urbani A, Fasano M, Alberio T
Front Cell Neurosci. 2015; 9:14.
PMID: 25698928
PMC: 4313704.
DOI: 10.3389/fncel.2015.00014.
Resveratrol Protects from Toxin-Induced Parkinsonism: Plethora of Proofs Hitherto Petty Translational Value.
Rasheed M, Tripathi M, Mishra A, Shukla S, Singh M
Mol Neurobiol. 2015; 53(5):2751-2760.
PMID: 25691456
DOI: 10.1007/s12035-015-9124-3.
Biomarkers of Parkinson's disease: present and future.
Miller D, OCallaghan J
Metabolism. 2014; 64(3 Suppl 1):S40-6.
PMID: 25510818
PMC: 4721253.
DOI: 10.1016/j.metabol.2014.10.030.
Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons.
Prakash J, Chouhan S, Yadav S, Westfall S, Rai S, Singh S
Neurochem Res. 2014; 39(12):2527-36.
PMID: 25403619
DOI: 10.1007/s11064-014-1443-7.
Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.
Agrawal S, Dixit A, Singh A, Tripathi P, Singh D, Patel D
Mol Neurobiol. 2014; 52(3):1619-1628.
PMID: 25370934
DOI: 10.1007/s12035-014-8954-8.
Cypermethrin alters the status of oxidative stress in the peripheral blood: relevance to Parkinsonism.
Tripathi P, Singh A, Agrawal S, Prakash O, Singh M
J Physiol Biochem. 2014; 70(4):915-24.
PMID: 25270427
DOI: 10.1007/s13105-014-0359-7.
Aberrant autophagy and parkinsonism: does correction rescue from disease progression?.
Mishra A, Rasheed M, Shukla S, Tripathi M, Dixit A, Singh M
Mol Neurobiol. 2014; 51(3):893-908.
PMID: 24833602
DOI: 10.1007/s12035-014-8744-3.
Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology.
Pan-Montojo F, Reichmann H
Transl Neurodegener. 2014; 3:10.
PMID: 24826210
PMC: 4019355.
DOI: 10.1186/2047-9158-3-10.
Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study.
Agrawal S, Singh A, Tripathi P, Mishra M, Singh P, Singh M
Mol Neurobiol. 2014; 51(2):448-65.
PMID: 24760363
DOI: 10.1007/s12035-014-8696-7.